Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong · Delayed Price · Currency is HKD
1.400
+0.060 (4.48%)
At close: Mar 10, 2026
Revenue by Segment
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 553.24M | 467.28M | 733.34M | 749.14M | 677.95M | | | | | |
Licensed-In Products Growth | 18.40% | -36.28% | -2.11% | 10.50% | -0.78% | | | | | |
Proprietary and Generic Products | 846.73M | 585.76M | 499.81M | 517.02M | 538.77M | | | | | |
Proprietary and Generic Products Growth | 44.55% | 17.20% | -3.33% | -4.04% | 0.59% | | | | | |
| 1.40B | 1.05B | 1.23B | 1.27B | 1.22B | | | | | |
| 32.95% | -14.61% | -2.61% | 4.06% | -0.18% | | | | | |
Revenue by Geography
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
The People's Republic of China (The PRC) | 1.40B | 1.05B | 1.23B | 1.27B | 1.22B | | | | | |
The People's Republic of China (The PRC) Growth | 32.95% | -14.61% | -2.61% | 4.06% | -0.18% | | | | | |
| 1.40B | 1.05B | 1.23B | 1.27B | 1.22B | | | | | |
| 32.95% | -14.61% | -2.61% | 4.06% | -0.18% | | | | | |
Source: S&P Global Market Intelligence.
